GO:0006402 mRNA catabolic process: Decay Pathway

The Gene Ontology term GO:0006402, mRNA catabolic process, defines the chemical reactions and pathways that result in the breakdown of messenger RNA (mRNA), the RNA species responsible for carrying the coded genetic message from DNA to the ribosomes for protein assembly. This process, also known as mRNA decay or mRNA degradation, is a fundamental post-transcriptional regulatory layer that determines the steady-state level and translational output of every transcript in a cell. Because mRNA half-lives vary widely and are influenced by codon optimality, RNA modifications, and trans-acting factors, the catabolic machinery is central to gene expression control. Research into mRNA catabolic process has revealed that decay is not a passive event but an actively regulated pathway that intersects with translation, RNA modification, and cellular stress responses. For example, internal 2'-O-methylation on mRNA promotes stability, directly linking chemical modification to catabolic fate. Similarly, m7G-mediated stabilization of specific transcripts can suppress autophagy and promote cancer progression, illustrating how decay regulation impacts disease. Extracellular exosomal RNAs are also glyco-modified, suggesting that mRNA catabolism and RNA modification extend beyond the intracellular space. Understanding GO:0006402 is therefore essential for researchers in RNA biology, cancer, immunology, and therapeutic development. The pathway involves a complex network of enzymes, RNA-binding proteins, and subcellular compartments, including processing bodies (P-bodies) and exosomes. This article provides a research-grade overview of the definition, mechanisms, key genes, disease links, and experimental models used to study mRNA catabolic process, with all facts grounded in published literature.

In our own words, GO:0006402 (mRNA catabolic process) encompasses all biochemical reactions and pathways that lead to the breakdown of messenger RNA. This includes the removal of the poly(A) tail, decapping, exonucleolytic digestion from either end, and endonucleolytic cleavage, ultimately reducing the pool of translatable mRNA. The process is highly regulated and can be coupled to translation, RNA quality control, and cellular stress responses.

mRNA catabolic process is critically important because it sets the lifetime of every transcript and thus directly controls protein expression levels, cellular responses to stress, and the quality of the proteome. Dysregulation of mRNA decay can lead to accumulation of aberrant transcripts, altered immune responses, and cancer progression. Moreover, therapeutic mRNA vaccines and RNA-based therapeutics depend on understanding and manipulating mRNA stability.

The following genes and proteins are central to mRNA catabolic process, based on published literature.

mRNA catabolic process is regulated at multiple levels. RNA modifications such as 2'-O-methylation and m7G capping directly influence transcript stability and decay rates. Codon optimality and translation efficiency are coupled to decay, meaning that poorly translated mRNAs are often targeted for degradation. Cellular stress can trigger the assembly of RNA granules, which sequester mRNAs and modulate their catabolism. Additionally, extracellular exosomal RNAs can be glyco-modified, suggesting that mRNA catabolism is also regulated in the extracellular environment. Cell death pathways, including apoptosis, intersect with mRNA decay regulation.

Dysregulated mRNA decay contributes to cancer progression. The P300/ETV4-WDR4 axis promotes colorectal cancer progression via m7G-mediated SPP1 mRNA stabilization and autophagy suppression. This demonstrates how altered mRNA catabolism can drive oncogenic phenotypes. Targeting decay factors such as WDR4 may offer therapeutic opportunities.

Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. This highlights the importance of mRNA catabolism in vaccine design and immunotherapy. Extracellular exosomal RNAs are glyco-modified, which may influence immune recognition and RNA stability.

Cell death pathways are closely linked to mRNA decay regulation, as RNA granules and decay factors can influence apoptosis. Dysfunctional mRNA catabolism may contribute to neurodegeneration through accumulation of aberrant transcripts, although specific mechanisms require further study.

RNA-seq can measure steady-state mRNA levels, while metabolic labeling (e.g., SLAM-seq) or transcription inhibition (e.g., actinomycin D) allows calculation of mRNA half-lives. These methods are essential to identify transcripts regulated by mRNA catabolic process.

Ribo-seq measures ribosome occupancy and translation efficiency, which is coupled to mRNA decay. Codon optimality and translation elongation rates influence mRNA stability, making Ribo-seq a key tool.

Mass spectrometry-based proteomics can identify proteins associated with mRNA decay complexes, such as decapping enzymes and exosome components. This helps define the composition of RNA granules.

Fluorescence microscopy of P-bodies and stress granules using tagged markers allows real-time visualization of mRNA catabolism in living cells.

Researchers studying mRNA catabolic process-related genes often need to determine whether a candidate gene is causally involved in transcript stability, disease progression, or therapeutic response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.

GO:0006402 mRNA catabolic process is a fundamental biological pathway that controls the lifetime and abundance of every messenger RNA, thereby shaping gene expression, cellular stress responses, and disease outcomes. The integration of RNA modifications, translation efficiency, and compartmentalization makes mRNA decay a highly regulated and dynamic process. Understanding its mechanisms offers opportunities for therapeutic intervention in cancer, immune disorders, and RNA-based therapies. Researchers can leverage EDITGENE's CRISPR services to create precise cell models and uncover causal roles of mRNA catabolism genes. By combining knockout, knock-in, point mutation, and overexpression strategies with advanced bioinformatics, the field can continue to reveal how mRNA decay contributes to health and disease.